Skip to main content
. 2022 Apr 12;10(4):e004424. doi: 10.1136/jitc-2021-004424

Figure 1.

Figure 1

Trial design. HNSCC, head and neck squamous cell carcinoma; NSCLC, non–small cell lung cancer; PD-1, programmed cell death-1; PD-L1, programmed death-ligand 1.